- Solid Tumors
- Pipeline Molecules
- Alliance Partners
Our mission is to provide healthcare professionals with unbiased clinical research information, easily.
Currently, you can access the following clinical trials being conducted worldwide:
Clinicaltrials.gov identifier NCT03941379
Recruitment Status Recruiting
First Posted May 7, 2019
Last update posted August 7, 2020
The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness of AU-011 and standard of care therapy. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care.
This is a multi-center long-term observational Registry of patients with Primary Choroidal Melanoma (CM) or Indeterminate Lesions (ILs) The Registry will initially be open to patients who have previously participated in an Aura Biosciences sponsored clinical trial for their primary Choroidal Melanoma or Indeterminate Lesions. All patients will be followed for a minimum of 5 years (including time enrolled in an Aura sponsored clinical trial), until withdrawal of consent, or until death whichever comes first. No interventions will be required as part of the Registry. Data collection will be based on information anticipated to be available based on the standard of care for patients with CM or IL; these patients are routinely followed at 6-month intervals by their treating physician.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, , Learn About Clinical Studies.-->
- Have been clinically diagnosed with primary CM or IL at the time of entry to a
previous Aura Biosciences sponsored clinical trial.
- Have received AU-011 or assigned to an observation cohort in a previous Aura sponsored
Contact: Rochelle Summerfelt, MS (773) 855-8157 email@example.com
Contact: Abhijit Narvekar, MBBS MS DPM 617-250-7255 firstname.lastname@example.org
United States, Massachusetts
Massachusetts Eye and Ear Infirmary
United States, Michigan
W. K. Kellogg Eye Center, University of Michigan
United States, Michigan
Associated Retinal Consultants, PC
United States, Minnesota
United States, Pennsylvania
Wills Eye Hospital
United States, Texas
Retina Consultants of Houston
Study Director: Abhijit Narvekar, MBBS MS DPM Aura Biosciences Inc.